Role of KLK Antibodies in Cancer Diagnosis and Treatment

KLK Antibodies 

 Are proteins that specifically target and bind to kallikrein proteins, which are involved in various physiological processes. They are used in research, diagnostics, and potential therapies for diseases like cancer.


Cancer Biomarker Detection

Kallikrein proteins, including members of the KLK family, are often dysregulated in various types of cancer.

Prognostic Indicator  

Elevated levels of certain KLK proteins have been associated with poor prognosis in several types of cancer 

Therapeutic Targeting

In addition to their diagnostic utility, KLK antibodies may have therapeutic potential in cancer treatment 

Research Tools

KLK antibodies are valuable research tools for studying the physiological roles of kallikrein proteins in normal tissue homeostasis and disease states.





KLK antibodies are highly specific to their target kallikrein proteins, enabling precise detection and modulation of kallikrein activity.

Diagnostic Potential

KLK antibodies serve as valuable tools in diagnostic assays, aiding in the detection and quantification of kallikrein proteins as potential biomarkers for diseases such as cancer.

Therapeutic Potential

KLK antibodies hold promise as therapeutic agents for conditions where dysregulated kallikrein activity contributes to pathology, offering targeted treatment options.

Research Tools

They are instrumental in elucidating the physiological roles of kallikrein proteins and their involvement in disease processes through techniques such as western blotting, immunoprecipitation, and immunofluorescence

Your Dynamic Snippet will be displayed here... This message is displayed because you did not provided both a filter and a template to use.
Monoclonal anti-Influenza Virus type B Antibodies: Promising Approach for Influenza Management